Objective: To investigate the effects of estrogen on left ventricle (LV) mass and collagen deposition, and on the expression of receptors for estrogen (ERa, ERb) and Ang II (AT R, AT R) in the heart of aged female rats. Methods: Aged (|12 months old) intact (n57), 2 1 ovariectomized plus placebo (OVX, n57), and estrogen-replaced (E2, n56) as well as young (|3 months old, n54) female Sprague-Dawley rats were used in this study. After 1 month of treatment, the left ventricular weight / body weight ratio (LVW/ BW), changes in myosin heavy chain expression (MHC), matrix metalloproteinase (MMP)-2 activity, the collagen I / III ratio, and the expression of ERs and Ang II receptors in the LV were evaluated. Results: In aged rats, OVX increased LVW/ BW associated with a higher expression of b-MHC isoform, increased collagen I / III ratio, and decreased MMP-2 activity compared to intact rats. Furthermore, the OVX group had a decrease in ERs a and b as well as AT R but an increase in AT R expression. Estrogen replacement prevented the 2 1 effects of ovariectomy on heart remodeling as well as increased further expression of ERb and decreased AT R expression. Conclusion:
. Introduction
higher in women [5] . Several studies have also reported that women receiving hormone replacement therapy (HRT) Aging is associated with increased heart remodeling.
presented lower LV mass and LV dimensions compared Senescent hearts present phenotypic changes in myocardial with woman without HRT [6, 7] . Moreover, HRT has been tissue that include hypertrophy and modifications in the shown to attenuate the development of LVH in hypertencontractile machinery of cardiac myocytes, such as a shift sive postmenopausal women [8] . of myosin isoforms, as well as alterations on the extracelAlthough these observations indicate that estrogen may lular matrix (ECM) that lead to collagen accumulation attenuate heart remodeling related to aging, the mecha-[1,2]. These changes promote fibrosis and ventricular nisms involved in this modulation remain unclear. Esstiffness, which may cause electrical and mechanical trogen is known to have multiple effects on the heart [9] . alterations; thus, resulting in predisposition to heart failure, Indeed, cardiac myocytes and cardiac fibroblasts contain arrhythmias, and sudden death [1, 2] . both known estrogen receptor isoforms (ERa and ERb) Population studies have shown that in women the [9] . However, the effect of aging on the expression of ERs increment of heart mass for increment of age is higher than in the heart has not been fully addressed. in men, with these differences being more apparent after Angiotensin II (Ang II) is considered to play a key role menopause [3, 4] . Furthermore, the impact of left ventricuin the pathophysiology of heart hypertrophy and remodellar hypertrophy (LVH) on morbidity and mortality is also ing [10] . Ang II type I receptor (AT ) has been shown to 1 be upregulated in senescent hearts as well as in hypertrophied and failing hearts [11] . Estrogen has been reported to downregulate the expression of AT [11] , phate-buffered saline (PBS) and then dissected into left 1 reduce the activity of the angiotensin converting enzyme ventricle, left atrium, right ventricle and septum. Sections (ACE) [12] , and as recently reported, may directly anwere weighed and then snap frozen in liquid nitrogen and tagonize the growth-induced effects of Ang II by attenuatstored at 280 8C for subsequent biochemical assays. ing the AT mediated ERK activation [13] . Furthermore, 1 estrogen downregulates the activity of MAPK pathways, 2 .3. Analysis of myosin heavy chain isoforms involved in myocyte growth and in the development of heart failure after LVH [14] [15] [16] . Although these observaIsoforms of myosin heavy chain (MHC) were separated tions indicate that estrogen can modulate the cardiac by SDS-PAGE and quantified by Coomassie blue staining effects of Ang II, its effects on the expression of Ang II [19] . Myocyte homogenates in 23 Laemmli buffer were receptors in the aged heart remain unclear.
incubated at 100 8C for 5 min, loaded onto a 0.75-mm In addition to its anti-proliferative effects, estrogen may thick 0.1% SDS-4% polyacrylamide gel, and separated have antifibrotic effects by both inhibiting collagen syn-(Protean II; Bio-Rad). Gels were fixed, stained with thesis and enhancing its degradation. The effects of Coomassie blue and dried. Bands representing a-and estrogen on collagen turnover in the aged heart have also b-MHC were quantified by densitometric analysis (Quantibeen overlooked. In this study, we evaluated the effects of ty One; Bio-Rad). estrogen on LV mass and collagen deposition in the heart of aged female rats. Furthermore, we investigated the 2 .4. Zymography influence of aging and hormone status, on the expression of ERs and Ang II receptors in the heart. We hypothesized Homogenized LV tissue was suspended in 2 ml PBS that estrogen could attenuate the remodeling changes of the (pH 7.4) with 100 mg / ml phenylmethylsulfonyl fluoride aged heart, and that these changes will be associated with (PMSF) and 2 mg / ml leupeptin, and incubated at 4 8C for modulation of the expression of Ang II receptors.
20 h. The sample was then centrifuged at 12 0003g at 4 8C for 10 min. The resulting supernatant was employed for total protein assay and zymographic analysis [20] . To 2 . Methods analyze gelatinolytic activity, supernatant were mixed with 63 sample buffer (0.5 M Tris-HCl (pH 6.8), 10% SDS, 2 .1. Animal model 50% glycerol, 0.5% bromophenol blue). Twenty-five micrograms of protein was loaded per lane. After electroFemale Sprague-Dawley rats were obtained from phoresis, gels were washed 3320 min in 2.5% Triton Charles River and aged (11-12 months) in facilities at the X-100 at room temperature, followed by 24 h at 37 8C in University of Alberta. Ovariectomies were performed in enzyme assay buffer (25 mM Tris (pH 7.5), 5 mM CaCl , 2 the aged rats in order to control for variable estrogen 0.9% NaCl, 0.05% Na N) for development of enzyme 3 levels, which occur as rats approach reproductive senesactivity bands. Thereafter, the gels were stained with cence. At the time of ovariectomy, rats received either an 0.05% Coomassie blue, and de-stained in acetic acid and estrogen pellet (17b-estradiol, 7.5 mg / pellet, 125 mg / day methanol. Zymograms were analyzed for pro-and activerelease, Innovative Research of America; n56) or a MMP-2 with molecular weights of 72 and 69 kDa, placebo pellet (Innovative Research of America; n57) respectively. Gels were scanned using Fluor MultiImager subcutaneously. The dose of estrogen took into account the (Bio-Rad). larger size of the aged rats and was calculated based on our previous studies [17] , and previous data in the literature 2 .5. Western blot [18] . Confirmation of estrogen status was determined by uterine weight. Aged, intact (intact, n57) rats were used as Aliquots of ground LV were sonicated in homogenizacontrols for both OVX and estrogen-replaced animals.
tion solution (2% SDS, 100 mmol / l dithiothreitol, and 60 Young animals (n54) were used as a comparative refermmol / l Tris (pH 6.8) at 4 8C. Protein concentrations were ence group for the aged rats. After 1 month of treatment, determined with the use of the method of Bradford. Fourrats were killed on the day of the experiment by exsanguitimes SDS gels loading buffer (100 mmol / l Tris-HCl, pH nation, under anesthesia from an intraperitoneal injection 6.8), 200 mmol / l dithiothreitol, 4% SDS, 0.2% bromoof sodium pentobarbital (60 mg / kg body weight). The phenol blue, and 20% glycerol) were added, and samples animal protocols were examined and approved by the were heated to 100 8C for 10 min. Twenty-five micrograms University of Alberta Animal Welfare Committee which of protein of the supernatant was run through a 10% followed the guidelines outlined by the Canada Council on polyacrylamide gel followed by electrotransfer to nitroAnimal Care.
cellulose at 4 8C. Membranes were then incubated in 5% nonfat dry milk in PBS for 3 h and washed with PBS-2 .2. Heart preparation Tween-(0.1%). Primary antibodies, Collagen type I (1:1000, Santa Cruz), Collagen type III (1:1000, Santa Each heart was rapidly excised and immersed in phosCruz), Estrogen receptor a (1:1000, Santa Cruz), Estrogen receptor b (1:500, Santa Cruz), AT (1:500, Santa Cruz), was prevented by estrogen treatment (Fig. 1) . Importantly, 1 and AT (1:500, Santa Cruz) were incubated with the there was a shift of MHC with an enhancement of the fetal 2 membrane for 3 h at room temperature. The secondary b isoform in the OVX animals, which was not seen, in the antibody, goat anti-rabbit antibody or donkey anti-goat other groups (Fig. 1 ). In addition, collagen type I / III (Santa Cruz) was diluted to 1:4000 and incubated with the protein ratio increased 2-fold in OVX rats compared to the membrane for 1 h at room temperature. After the last other groups (Fig. 2) . Moreover, MMP-2 activity was washing step, enzyme-linked chemiluminescence detection significantly reduced in the OVX group compared to the was carried out according to the manufacturer's instrucyoung or other aged groups (Fig. 3) Body weight (BW) was significantly increased in aged substantially reduced by the estrogen treatment (Fig. 6 ). intact and OVX rats compared to young (Table 1) .
AT R expression was reduced in OVX rats that was 2 Estrogen replacement significantly reduced BW compared restored to the levels seen in the young by estrogen to the other aged animals. As expected, uterine weights replacement (Fig. 7) . (UW) and the UW/ BW ratio, a biological marker of estrogen status, were enhanced in the estrogen group compared to all other groups (Table 1) .
. Discussion

.2. Effect of aging and estrogen on left ventricular
This study evaluated the effects of aging and estrogen remodeling on left ventricular weight and remodeling of hearts from aged female rats. Our primary findings are that in the OVX Left ventricular weight (LVW) was increased in aged, group: (1) LVW/ BW was increased, (2) LVH was associintact rats compared to young, but this can be attributed to ated with the expression of the b-MHC isoform, (3) the the increased body size of the aged animals since LVW/ deposition of collagen I was further increased whereas BW were similar (Table 1) . Ovariectomy in the aged rats collagen III was reduced, and (4) MMP-2 activity was also increased LV weight and LV/ BW ratio in comparison to reduced. Estrogen replacement was associated with a intact and estrogen-replaced aged groups (Table 1) . Right decrease in LVW/ BW and collagen I / III ratios, reduction ventricular weight (RVW) and RVW/ BW ratio were not in b-MHC expression and enhanced MMP-2 activity in the different among groups (data not shown).
left ventricle. Furthermore, these changes were associated Since LV size was different in OVX aged animals, with increased expression of ERa, b and AT R, and 2 further assessment of remodeling was conducted. In the LV decreased AT R expression.
1 of OVX rats, the expression of a-MHC was reduced which These results indicate that in this model of aging, female rats, removal of ovarian hormones enhanced heart reincrease in women than in men [3,4]. Moreover, some modeling. These effects could be attenuated by estrogen studies have shown that blood pressure, body size, and replacement, suggesting a role of estrogen in the modulastroke volume may explain only 50% of the variance in tion of LV remodeling. Moreover, these data also suggest mass between men and women [21] . Therefore, other that the local myocardial angiotensin system may be factors such as sex hormones could be important deterinvolved in the mediation of estrogen effects on heart minants of ventricular mass. Indeed, it has been reported remodeling, and that the expression of ERs is modulated that hypertensive premenopausal women have smaller by the hormone status. ventricular mass than men matched by age and race, and with the same level of arterial pressure [22] . However, 4 .1. Left ventricular mass these sex differences tend to disappear in postmenopausal women, suggesting that the ovarian function may protect Population studies have shown that aging is associated against LVH and heart remodeling [22] . with an increase in LV weight, with a relative higher replaced animals. It has been previously reported that In the present study, we found that intact aged rats had estrogen may inhibit the development of LVH in sinoaortic an increase in LV weight compared to young rats, but denervated rats [23] , and that in ovariectomized mice without significant changes in the LVW/ BW ratio. Howsubjected to pressure overload hypertrophy, estrogen reever, OVX dramatically increased LVW/ BW ratio, and placement attenuated the hypertrophic response [14] . was associated with an enhancement of the expression of These observations strongly suggest that estrogen can the fetal isoform b-MHC, characteristic of hypertrophied modulate myocyte hypertrophy. and failing hearts, suggesting that estrogen deprivation may greatly affect the heart performance in these aged 4 .2. Expression of ERs and AngII receptors animals. Accordingly, estrogen replacement significantly reduced the LVW/ BW ratio in OVX aged rats. ImportantIt has been described that left ventricles from senescent ly, the reduction in the LVW/ BW ratio was present even hearts present an upregulation of the expression of Ang II with the concomitant decrease in the BW of the estrogen- receptors [24] , and of angiotensinogen and ACE myocarwith young rats, but significantly reduced in the ovariecdial mRNA levels [25] . Interestingly, the upregulation of tomized group. Moreover, estrogen replacement not only Ang II receptors does not occur in the right ventricle, blunted this further reduction in expression, but also was where mass does not increase with age [1] . In the present associated with an enhancement of MMP-2 activity to a study we found that the LV of OVX rats had an increased level similar to that of young rats. These results agree with expression of AT receptors, which was significantly our previous findings in mesenteric arteries of aged rats, 1 reduced by estrogen replacement. Indeed, estrogen replacewhere estrogen replacement was associated with an enment in the aged animals reduced expression of AT hancement of MMP-2 expression [34] . Accordingly, it has 1 receptors to levels below that of young rats. We speculate been recently reported that estradiol may upregulate the that unopposed estrogen in the absence of other ovarian synthesis of MMP-2 in mesangial cells by stimulating the hormones has striking effects on AT receptor expression.
synthesis of the transcription factor AP-2 via the MAPK 1 Moreover, estrogen replacement was associated with an cascade [35] . increase in the expression of AT receptors. Although the It has been recently proposed that an increase of the 2 role of AT in heart remodeling is not clear, it is thought androgens / estrogens ratio, with a relative predominance of 2 that AT may counter regulate the signaling of AT [10] , androgens could explain part of the pro-proliferative 2 1
and therefore its upregulation could have anti-proliferative effects associated with the decreased estrogen levels during effects. Furthermore, AT signaling has been found to menopause [36] . Androgens are known to induce myocyte 2 have antigrowth effects in many tissues [10] . Thus, eshypertrophy, and to predispose to collagen accumulation trogen may affect LV hypertrophy by modulating the by enhancing the collagen synthesis and its degradation by expression of Ang II receptors on heart tissue. Whether or decreasing MMP-2 activity [37] . Interestingly, some not estrogen mediates Ang II receptor expression via its studies have also shown that androgens may increase the own receptor remains to be determined.
expression of AT receptors in some tissues [38] . We 1 It has previously been shown that the two distinct speculate that a balance between the effects of androgens subtypes of estrogen receptor (ERa and ERb) have been and estrogen may modulate heart remodeling, in part identified in cardiac myocytes and cardiac fibroblasts through changes in the expression of Ang II receptors. [9, 26] . Our data indicate that there is a down-regulation of In summary, our present study is supportive of a role for both ERa and ERb in OVX rats, and an upregulation of estrogen in the prevention of LV remodeling associated ERa and ERb, with estrogen replacement suggesting that with aging. Estrogen replacement reduced LV weight and estrogen may induce cardiovascular protective effects via the collagen I / III ratio while enhancing the activity of mechanisms involving ERs.
MMP-2. These effects of estrogen may be mediated through modulation of Ang II receptors, as well as its own 4 .3. Extracellular matrix of left ventricle receptors.
Myocardium contains primarily type I and type III collagen [27] . Their relative concentrations in the heart are A cknowledgements important determinants of its mechanical properties [1] . Collagen I has a higher tensile strength compared to This study was supported by Canadian Institute for collagen III, and its concentration is considered the main Health Research (CIHR). S. T. Davidge is a senior scholar contributor to diastolic stiffness [1] . In many species of the Alberta Heritage Foundation for Medical Research including humans, aging is associated with increased and CHIR. We thank Gregory Chan, Kenman Gan, and collagen concentration, along with a higher I to III Neelam Kainth for their technical assistance. collagen ratio within the heart [27] [28] [29] [30] [31] . Moreover, it has been shown that in spontaneously hypertensive rats, hypertrophied ventricles have an increase in the collagen type R eferences I to III ratio that can be reversed with ACE inhibitors [32] .
In the present study, we found that heart expression of collagen I and III was increased in ovariectomized rats. type III collagen ratio that was prevented by estrogen Further, it has been described that the activity of MMP- 
